Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.26.564156Source: DataRank Database

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.269. It has been cited 5 times.

N/A

0.269DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (54)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.269

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (24)

Lin Wang ORCID,Kevin Leung ORCID,Albert Wang ORCID,Senthilnath Lakshmanachetty ORCID,Marco Gallus ORCID

Live enrichment

PubMed:37961484 OpenAlex:https://openalex.org/W4387969603

National Institutes of Health

Grant: 5R35NS105068-05

Preclinical development of breakthrough immunotherapy for brain tumors

National Institutes of Health

Grant: 3R01LM013897-02S1

An informatics framework for single-cell multi-omics from clinical specimens

National Institutes of Health

Grant: 1R50CA274229-01

The Immortality and Evolution of Adult Brain Tumors

National Institutes of Health

Grant: 5P50CA097257-18

Brain Tumor SPORE Grant

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/11/02/2023.10.26.564156.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.10.26.564156

repositoryhttps://doi.org/10.1101/2023.10.26.564156

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37961484

Fields of Study

RNA Research and SplicingSingle-cell and spatial transcriptomicsRNA regulation and disease03 medical and health sciences0302 clinical medicine

Keywords

GliomaAlternative splicingComputational biologyAntigenBiologyCancer researchGeneticsGeneProteomics1.1 Normal biological development and functioningScienceImmunologyOncology and CarcinogenesisBioinformatics and Computational Biology610Receptor-Like Protein Tyrosine PhosphatasesIntratumoral heterogeneityArticleRare DiseasesCancer GenomicsAntigens, NeoplasmHistocompatibility Antigens6162.1 Biological and endogenous factorsHumansAntigensLong-read sequencingCancerBiomedical and Clinical SciencesReceptor-Like Protein Tyrosine Phosphatases, Class 5Human GenomeQNeurosciencesRBiological SciencesBrain DisordersClass 5Brain CancerSurfaceBulk RNA-sequencingAntigens, SurfaceNeoplasmMedicineRNAImmunotherapyGeneric health relevanceGlioblastomaNeojunctionBiotechnology

Sustainable Development Goals

SDG 0: Good health and well-being